QDEL
QuidelOrtho Corp
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$12.76
−1.16%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$12.94
From 52W high−63.93%
Volume1.42M
Market cap$875.02M
P/E (TTM)—
P/S (TTM)0.3x
Div yield—
Key dataOct 19, 2026
Open
$12.94
From 52W high
−63.93%
Volume
1.42M
Market cap
$875.02M
ValuationView details →
P/E (Fwd)
11.0x
EV/EBITDA
−10.0x
P/E (TTM)
—
RSI (14)
54.2
MomentumView details →
1D Return
−1.16%
YTD Return
−54.29%
SummaryUpdated Jun 1, 2026
QuidelOrtho Corporation (NASDAQ:QDEL) is a leading diagnostic testing company formed through the 2022 merger of Quidel Corporation and Ortho Clinical Diagnostics. Founded originally as Quidel in 1979, the company has evolved into a comprehensive diagnostics provider serving healthcare facilities worldwide. The company went public in 1991 and is headquartered in San Diego, California. QuidelOrtho operates across the full spectrum of diagnostic testing, from point-of-care rapid tests to sophisticated laboratory instruments, serving hospitals, clinical laboratories, blood banks, and physician offices globally.
Similar companies
Latest newsMore news →
QuidelOrtho announced equity awards to two newly hired non-executive employees under its 2026 Inducement Plan as an inducement to employment.4d agoQuidelOrtho Corporation amended its existing credit agreement with Bank of America, N.A. as administrative agent, resetting financial covenant levels through the fiscal quarter ending September 30, 2029 and adjusting interest rate pricing and fees.26d ago